Advances in herbal medicine for treatment of ischemic brain injury

Natural Product Communications

Volumn 9, Issue 7, 2014, Pages 1045-1055

  Ghosh, Nilanjan ^a   Ghosh, Rituparna ^a   Bhat, Zulfiqar A ^b   Mandal, Vivekananda ^c   Bachar, Sitesh C ^d   Nima, Namsa D ^e   Sunday, Otimenyin O ^f   Mandal, Subhash C ^g  

^a Dr B C Roy College of Pharmacy and Allied Health Sciences   (India)

^b UNIVERSITY OF KASHMIR   (India)

^c GURU GHASIDAS UNIVERSITY   (India)

^d UNIVERSITY OF DHAKA   (Bangladesh)

^e TEZPUR UNIVERSITY   (India)

^f UNIVERSITY OF JOS   (Nigeria)

^g JADAVPUR UNIVERSITY   (India)

Author keywords

Apoptosis; Blood brain barrier; Cerebral ischemia; Herbal drugs; Neurodegeneration; Oxidative stress

Indexed keywords

BAICALIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; FIBRINOLYTIC AGENT; FREE RADICAL; GINKGO BILOBA EXTRACT; GLUTAMIC ACID; HERBACEOUS AGENT; LIGUSTILIDE; NATURAL PRODUCT; NEUROPROTECTIVE AGENT; NEUROTRANSMITTER; PEONOL; RESVERATROL; SCUTELLARIN; SHIKONIN; TANSHINONE; TOLL LIKE RECEPTOR; WOGONIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN INJURY; BRAIN ISCHEMIA; DRUG ACTIVITY; EXCITOTOXICITY; FIBRINOLYTIC THERAPY; HERBAL MEDICINE; HUMAN; MEMBRANE DAMAGE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; UNSPECIFIED SIDE EFFECT;

BRAIN ISCHEMIA; HERBAL MEDICINE; HUMANS; PHYTOTHERAPY; STROKE;

EID: 84905125306     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1400900739     Document Type: Review

References (109)

1. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. (2006) The lifetime risk of stroke: estimates from the Framingham study. Stroke, 37, 345-350. (Pubitemid 43731985)
2. Beal CC. (2010) Gender and stroke symptoms: a review of the current literature. Journal of Neuroscience Nursing, 42, 80-87.
3. Mattson MP, Duan W, Pedersen WA, Culmsee C. (2001) Neurodegenerative disorders and ischemic brain diseases. Apoptosis, 6, 69-81. (Pubitemid 32233956)
4. Murray V, Norrving B, Sandercock PA, Terént A, Wardlaw JM, Wester P. (2010) The molecular basis of thrombolysis and its clinical application in stroke. Journal of International Medicine, 267, 191-208.
5. Arumugam TV, Granger DN, Mattson MP. (2005) Stroke and T-cells. Neuromolecular Medicine, 7, 229-242. (Pubitemid 41507146)
6. Mattson MP, Culmsee C, Yu ZF. (2000) Apoptotic and antiapoptotic mechanisms in stroke. Cell and Tissue Research, 301, 173-187. (Pubitemid 30459864)
7. Zheng Z, Zhao H, Steinberg GK, Yenari MA. (2003) Cellular and molecular events underlying ischemia-induced neuronal apoptosis. Drug News and Perspectives, 16, 497-503. (Pubitemid 37484368)
8. Mehta SL, Manhas N, Raghubir R. (2007) Molecular targets in cerebral ischemia for developing novel therapeutics. Brain ResearchReviews, 54, 34-66. (Pubitemid 46498164)
9. Ghosh N, Ghosh R, Mandal SC. (2011) Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease. Free Radical Research, 45, 888-905.
10. Crack PJ, Taylor JM. (2005) Reactive oxygen species and the modulation of stroke. Free Radical Biology and Medicine, 38, 1433-1444. (Pubitemid 40693828)
11. Saeed SA, Shad KF, Saleem T, Javed F, Khan MU. (2007) Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke. Experimental Brain Research, 182, 1-10. (Pubitemid 47318241)
12. Im JY, Kim D, Paik SG, Han PL. (2006) Cyclooxygenase 2 dependent neuronal death proceeds via superoxide anion generation. Free Radical Biology and Medicine, 41, 960-972. (Pubitemid 44247547)
13. Dawson VL, Dawson TM. (1998) Nitric oxide in neurodegeneration. Progress in Brain Research, 118, 215-229. (Pubitemid 28530669)
14. Bhardwaj A, Northington FJ, Martin LJ, Hanley DF, Traystman RJ, Koehler RC. (1997) Characterization of metabotropic glutamate receptor-mediated nitric oxide production in vivo. Journal of Cerebral Blood Flow & Metabolism, 17, 153-160. (Pubitemid 27085838)
15. Mattson MP. (2009) Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Experimental Gerontology, 44, 625-633.
16. Wang Q, Tang XN, Yenari MA. (2007) The inflammatory response in stroke. Journal of Neuroimmunology, 184, 53-68. (Pubitemid 46365991)
17. Zheng Z, Yenari MA. (2004) Post-ischemic inflammation: molecular mechanisms and therapeutic implications. NeurologicalResearch, 26, 884-892. (Pubitemid 39628566)
18. Huang J, Upadhyay UM, Tamargo RJ. (2006) Inflammation in stroke and focal cerebral ischemia. Surgical Neurology, 66, 232-245. (Pubitemid 44279808)
19. Thiel VE, Audus KL. (2001) Nitric oxide and blood-brain barrier integrity. Antioxidants and Redox Signaling, 3, 273-278. (Pubitemid 32473342)
20. Yang Y, Rosenberg GA. (2011) Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke, 42, 3323-3328.
21. Ishikawa M, Zhang JH, Nanda A, Granger DN. (2004) Inflammatory responses to ischemia and reperfusion in the cerebral microcirculation. Frontiers in Bioscience, 9, 1339-1347. (Pubitemid 39060847)
22. Zhu DY, Li R, Liu GQ, Hua WY. (2000) Tumor necrosis factor alpha enhances the cytotoxicity induced by nitric oxide in cultured cerebral endothelial cells. Life Sciences, 66, 1325-1335. (Pubitemid 30123204)
23. Dawson VL, Dawson TM. (2004) Deadly conversations: nuclear-mitochondrial cross-talk. Journal of Bioenergetics andBiomembranes, 36, 287-294.
24. Tan KH, Harrington S, Purcell WM, Hurst RD. (2004) Peroxynitrite mediates nitric oxide-induced blood-brain barrier damage. Neurochemical Research, 29, 579-587. (Pubitemid 38295008)
25. Kostandy BB. (2012) The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurological Sciences, 33, 223-237.
26. Camacho A, Massieu L. (2006) Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Archives of Medical Research, 37, 11-18. (Pubitemid 41727885)
27. Medzhitov R. (2007) Recognition of microorganisms and activation of the immune response. Nature, 449, 819-826.
28. Hua F, Ma J, Ha T, Xia Y, Kelley J, Williams DL, Kao RL, Browder IW, Schweitzer JB, Kalbfleisch JH, Li C. (2007) Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. Journal ofNeuroimmunology, 190, 101-111.
29. Okun E, Griffioen KJ, Lathia JD, Tang SC, Mattson MP, Arumugam TV. (2009) Toll-like receptors in neurodegeneration. BrainResearch Reviews, 59, 278-292.
30. Arroyo DS, Soria JA, Gaviglio EA, Rodriguez-Galan MC, Iribarren P. (2011) Toll-like receptors are key players in neurodegeneration. International Immunopharmacology, 11, 1415-1421.
31. Chen CY, Jang JH, Li MH, Surh YJ. (2005) Resveratrol upregulatesheme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochemical and Biophysical Research Communications, 331, 993-1000.
32. Simão F, Matté A, Matté C, Soares FM, Wyse AT, Netto CA, Salbego CG. (2011) Resveratrol prevents oxidative stress and inhibition of Na(+)K(+)-ATPase activity induced by transient global cerebral ischemia in rats. Journal of Nutritional Biochemistry, 22, 921-928.
33. Sakata Y, Zhuang H, Kwansa H, Koehler RC, Doré S. (2010) Resveratrol protects against experimental stroke: putative neuroprotective role of hemeoxygenase 1. Experimental Neurology, 224, 325-329.
34. Ren J, Fan C, Chen N, Huang J, Yang Q. (2011) Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. NeurochemicalResearch, 36, 2352-2362.
35. Li H, Yan Z, Zhu J, Yang J, He J. (2011) Neuroprotective effects of resveratrol on ischemic injury mediated by improving brain energy metabolism and alleviating oxidative stress in rats. Neuropharmacology, 60, 252-258.
36. Yousuf S, Atif F, Ahmad M, Hoda N, Ishrat T, Khan B, Islam F. (2009) Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Research, 1250, 242-253.
37. Simão F, Matté A, Pagnussat AS, Netto CA, Salbego CG. (2012) Resveratrol preconditioning modulates inflammatory response in the rat hippocampus following global cerebral ischemia. Neurochemistry International, 61, 659-665.
38. Li Z, Pang L, Fang F, Zhang G, Zhang J, Xie M, Wang L. (2012) Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2. Brain Research, 1450, 116-124.
39. Shin JA, Lee KE, Kim HS, Park EM. (2012) Acute resveratrol treatment modulates multiple signaling pathways in the ischemic brain. Neurochemical Research, 37, 2686-2896.
40. Simão F, Matté A, Pagnussat AS, Netto CA, Salbego CG. (2012) Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways. European Journal of Neurosciences, 36, 2899-2905.
41. Tan L, Yu JT, Guan HS. (2008) Resveratrol exerts pharmacological preconditioning by activating PGC-1alpha. Medical Hypotheses, 71, 664-667.
42. Raval AP, Lin HW, Dave KR, Defazio RA, Della Morte D, Kim EJ, Perez-Pinzon MA. (2008) Resveratrol and ischemic preconditioning in the brain. Current Medicinal Chemistry, 15, 1545-1551. (Pubitemid 351997786)
43. Raval AP, Dave KR, Pérez-Pinzón MA. (2006) Resveratrol mimics ischemic preconditioning in the brain. Journal of Cerebral Blood Flow and Metabolism,26, 1141-1147. (Pubitemid 44268176)
44. Clark D, Tuor UI, Thompson R, Institoris A, Kulynych A, Zhang X, Kinniburgh DW, Bari F, Busija DW, Barber PA. (2012) Protection against recurrent stroke with resveratrol: endothelial protection. PLoS One, 7, e47792.
45. Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA. (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience, 159, 993-1002.
46. Li C, Yan Z, Yang J, Chen H, Li H, Jiang Y, Zhang Z. (2010) Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats. Neurochemistry International, 56, 495-500.
47. Bridi R, Crossetti FP, Steffen VM, Henriques AT. (2001) The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats. PhytotherapyResearch, 15, 449-451. (Pubitemid 32762399)
48. Tulsulkar J, Shah ZA. (2013) Ginkgo bilobaprevents transient global ischemia-induced delayed hippocampal neuronal death through antioxidant and anti-inflammatory mechanism. Neurochemistry International, 62, 189-197.
49. Shah ZA, Nada SE, Dore S. (2011) Hemeoxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761) neuroprotection. Neuroscience, 180, 248-255.
50. Nada SE, Shah ZA. (2012) Preconditioning with Ginkgo biloba (EGb 761) provides neuroprotection through HO1 and CRMP2. Neurobiology of Disease, 46, 180-189.
51. Pierre S, Jamme I, Droy-Lefaix MT, Nouvelot A, Maixent JM. (1999) Ginkgo biloba extract (EGb 761) protects Na,K-ATPase activity during cerebral ischemia in mice. Neuroreport, 10, 47-51. (Pubitemid 29090476)
52. Mdzinarishvili A, Sumbria R, Lang D, Klein J. (2012) Ginkgo extract EGb761 confers neuroprotection by reduction of glutamate release in ischemic brain. Journal of Pharmacy and Pharmaceutical Sciences, 15, 94-102.
53. Xiao ZY, Sun CK, Xiao XW, Lin YZ, Li S, Ma H, Song GR, Cheng R. (2006) Effects of Ginkgobiloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof. Zhonghua Yi Xue Za Zhi, 86, 2479-2484. (Pubitemid 44829031)
54. Hu B, Sun S, Mei G, Chen L, Tong E. (2002) Protective effects of Ginkgo biloba extract on rats during cerebral ischemia/reperfusion. Chinese Medical Journal, 115, 1316-1320.
55. Yang ZZ, Li J, Li SX, Feng W, Wang H. (2011) Effect of ginkgolide B on striatal extracellular amino acids in middle cerebral artery occluded rats. Journal of Ethnopharmacology, 136, 117-122.
56. Zhang Z, Peng D, Zhu H, Wang X. (2012) Experimental evidence of Ginkgo bilobaextract EGB as a neuroprotective agent in ischemia stroke rats. Brain Research Bulletin, 87, 193-198.
57. Cho JH, Sung JH, Cho EH, Won CK, Lee HJ, Kim MO, Koh PO. (2009) Gingko biloba extract (EGb 761) prevents ischemic brain injury by activation of the Akt signaling pathway. American Journal of Chinese Medicine, 37, 547-555.
58. Koh PO. (2011) Gingko biloba extract (EGb 761) attenuates the focal cerebral ischemic injury-induced decrease in astrocyticphosphoprotein PEA-15 levels. The American Journal of Chinese Medicine, 39, 971-979.
59. Lu G, Wu Y, Mak YT, Wai SM, Feng ZT, Rudd JA, Yew DT. (2006) Molecular evidence of the neuroprotective effect of Ginkgo biloba (EGb761) using bax/bcl-2 ratio after brain ischemia in senescence-accelerated mice, strain prone-8. Brain Research, 1090, 23-28. (Pubitemid 43833445)
60. Ma S, Yin H, Chen L, Liu H, Zhao M, Zhang X. (2012) Neuroprotective effect of ginkgolide K against acute ischemic stroke on middle cerebral ischemia occlusion in rats. Journal of Natural Medicine, 66, 25-31.
61. Ghoneim AI, Abdel-Naim AB, Khalifa AE, El-Denshary ES. (2002) Protective effects of curcumin against ischaemia/reperfusion insult in rat forebrain. Pharmacological Research, 46, 273-279. (Pubitemid 35300767)
62. Al-Omar FA, Nagi MN, Abdulgadir MM, Al Joni KS, Al-Majed AA. (2006) Immediate and delayed treatments with curcumin prevent forebrain ischemia-induced neuronal damage and oxidative insult in the rat hippocampus. Neurochemical Research, 31, 611-618. (Pubitemid 43886409)
63. Thiyagarajan M, Sharma SS. (2004) Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sciences, 74, 969-985. (Pubitemid 37522132)
64. Shukla PK, Khanna VK, Ali MM, Khan MY, Srimal RC. (2008) Anti-ischemic effect of curcumin in rat brain. Neurochemical Research,33, 1036-1043.
65. Balogun E, Hoque M, Gong P, Killeen E, Green CJ, Foresti R, Alam J, Motterlini R. (2003) Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. The Biochemical Journal, 371, 887-895. (Pubitemid 36578887)
66. Yang C, Zhang X, Fan H, Liu Y. (2009) Curcuminupregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Research, 1282, 133-141.
67. Wang Q, Sun AY, Simonyi A, Jensen MD, Shelat PB, Rottinghaus GE, MacDonald RS, Miller DK, Lubahn DE, Weisman GA, Sun GY. (2005) Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. Journal of Neuroscience Research, 82, 138-148. (Pubitemid 41604805)
68. Zhao J, Yu S, Zheng W, Feng G, Luo G, Wang L, Zhao Y. (2010) Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochemical Research, 35, 374-379.
69. Zhuang R, Lin MX, Song QY, Li J. (2009) Effects of curcumin on the expression of nuclear factor-kappaB and intercellular adhesion molecular 1 in rats with cerebral ischemia-reperfusion injury. Nan Fang Yi Ke Da XueXueBao, 29, 1153-1155.
70. Jiang J, Wang W, Sun YJ, Hu M, Li F, Zhu DY. (2007) Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. European Journal of Pharmacology, 561, 54-62. (Pubitemid 46435844)
71. Wu CC, Hsu MC, Hsieh CW, Lin JB, Lai PH, Wung BS. (2006) Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sciences, 78, 2889-2897.
72. Romeo L, Intrieri M, D'Agata V, Mangano NG, Oriani G, Ontario ML, Scapagnini G. (2009) The major green tea polyphenol, (-)-epigallocatechin-3- gallate, induces hemeoxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. Journal of American College of Nutrition, 28 Suppl:492S-499S.
73. Lee S, Suh S, Kim S. (2000) Protective effects of the green tea polyphenol (-)-pigallocatechingallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neuroscience Letters, 287, 191-194. (Pubitemid 30339381)
74. Choi YB, Kim YI, Lee KS, Kim BS, Kim DJ. (2004) Protective effect of epigallocatechingallate on brain damage after transient middle cerebral artery occlusion in rats. Brain Research, 1019, 47-54. (Pubitemid 39078609)
75. Nagai K, Jiang MH, Hada J, Nagata T, Yajima Y, Yamamoto S, Nishizaki T. (2002) (-)-Epigallocatechingallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant. Brain Research, 956, 319-322. (Pubitemid 35351399)
76. Wei IH, Wu YC, Wen CY, Shieh JY. (2004) Green tea polyphenol (-)-epigallocatechingallate attenuates the neuronal NADPH-d/nNOS expression in the nodose ganglion of acute hypoxic rats. Brain Research, 999, 73-80.
77. Wei IH, Tu HC, Huang CC, Tsai MH, Tseng CY, Shieh JY. (2011) (-)-Epigallocatechingallate attenuates NADPH-d/nNOS expression in motor neurons of rats following peripheral nerve injury. BMC Neuroscience, 12, 52.
78. Lee H, Bae JH, Lee SR. (2004) Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. Journal of Neuroscience Research, 77, 892-900. (Pubitemid 39187072)
79. Ding J, Fu G, Zhao Y, Cheng Z, Chen Y, Zhao B, He W, Guo LJ. (2012) EGCG ameliorates the suppression of long-term potentiation induced by ischemia at the Schaffer collateral-CA1 synapse in the rat. Cellular and Molecular Neurobiology, 32, 267-277
80. Wu KJ, Hsieh MT, Wu CR, Wood WG, Chen YF. (2012) Green tea extract ameliorates learning and memory deficits in ischemic rats via its active component polyphenol epigallocatechin-3-gallate by modulation of oxidative stress and neuroinflammation. Evidence Based Complementary and Alternative Medicine, 2012, 163106.
81. Park JW, Jang YH, Kim JM, Lee H, Park WK, Lim MB, Chu YK, Lo EH, Lee SR. (2009) Green tea polyphenol (-)-epigallocatechingallate reduces neuronal cell damage and up-regulation of MMP-9 activity in hippocampal CA1 and CA2 areas following transient global cerebral ischemia. Journal of Neuroscience Research, 87, 567-575.
82. Jung JY, Han CR, Jeong YJ, Kim HJ, Lim HS, Lee KH, Park HO, Oh WM, Kim SH, Kim WJ. (2007) Epigallocatechingallate inhibits nitric oxide-induced apoptosis in rat PC12 cells. Neuroscience Letters, 411, 222-227. (Pubitemid 44828279)
83. Yao K, Ye P, Zhang L, Tan J, Tang X, Zhang Y. (2008) Epigallocatechingallate protects against oxidative stress-induced mitochondria-dependent apoptosis in human lens epithelial cells. Molecular Vision, 14, 217-223. (Pubitemid 351223392)
84. Jung JY, Han CR, Jeong YJ, Kim HJ, Lim HS, Lee KH, Park HO, Oh WM, Kim SH, Kim WJ. (2007) Epigallocatechingallate inhibits nitric oxide-induced apoptosis in rat PC12 cells. Neuroscience Letters, 411, 222-227. (Pubitemid 44828279)
85. Zhang ZJ, Li P, Wang Z, Li PT, Zhang WS, Sun ZH, Zhang XJ, Wang YY. (2006) A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia-reperfusion injury. Brain Research, 1123, 188-195. (Pubitemid 44794386)
86. Tu XK, Yang WZ, Shi SS, Wang CH, Chen CM. (2009) Neuroprotective effect of baicalin in a rat model of permanent focal cerebral ischemia. Neurochemical Research, 34, 1626-1634
87. Li H, Hu J, Ma L, Yuan Z, Wang Y, Wang X, Xing D, Lei F, Du L. (2010) Comprehensive study of baicalin down-regulating NOD2 receptor expression of neurons with oxygen-glucose deprivation in vitro and cerebral ischemia-reperfusion in vivo. European Journal of Pharmacology,649, 92-99.
88. Tu XK, Yang WZ, Shi SS, Chen Y, Wang CH, Chen CM, Chen Z. (2011) Baicalin inhibits TLR2/4 signaling pathway in rat brain following permanent cerebral ischemia. Inflammation, 34, 463-470.
89. Xue X, Qu XJ, Yang Y, Sheng XH, Cheng F, Jiang EN, Wang JH, Bu W, Liu ZP. (2010) Baicalin attenuates focal cerebral ischemic reperfusion injury through inhibition of nuclear factor κB p65 activation. Biochemical and Biophysical Research Communications, 403, 398-404.
90. Cao Y, Mao X, Sun C, Zheng P, Gao J, Wang X, Min D, Sun H, Xie N, Cai J. (2011) Baicalin attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-oxidative and anti-apoptotic pathways. Brain Research Bulletin, 85, 396-402.
91. Tu XK, Yang WZ, Liang RS, Shi SS, Chen JP, Chen CM, Wang CH, Xie HS, Chen Y, Ouyang LQ. (2011) Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats. Neurochemical Research, 36, 2022-2028.
92. Zhu H, Wang Z, Xing Y, Gao Y, Ma T, Lou L, Lou J, Gao Y, Wang S, Wang Y. (2012) Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. Journal of Ethnopharmacology, 141, 714-720.
93. Mandal V, Gopal V, Mandal SC. (2012) An inside to the better understanding of the ethnobotanical route to drug discovery - the need of the hour. Natural Product Communications, 7, 1551-1554.
94. Kuang X, Yao Y, Du JR, Liu YX, Wang CY, Qian ZM. (2006) Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice. Brain Research, 1102, 145-153. (Pubitemid 44121580)
95. Yu Y, Du JR, Wang CY, Qian ZM. (2008) Protection against hydrogen peroxide-induced injury by Z-ligustilide in PC12 cells. Experimental Brain Research, 184, 307-312. (Pubitemid 350275878)
96. Dong K, Xu W, Yang J, Qiao H, Wu L. (2009) Neuroprotective effects of tanshinone IIA on permanent focal cerebral ischemia in mice. Phytotherapy Research, 23, 608-613.
97. Yu XY, Lin SG, Zhou ZW, Chen X, Liang J, Duan W, Yu XQ, Wen JY, Chowbay B, Li CG, Sheu FS, Chan E, Zhou SF. (2007) Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuro-protective activity in experimentally stroked rats. Neuroscience Letters, 417, 261-265. (Pubitemid 46589793)
98. Cai Q, Wang HW, Hua SY, Tan JZ, Zhou T, Li CS. (2012) Neuroprotective efficacy of sodium tanshinone B on hippocampus neuron in a rat model of focal cerebral ischemia. Chinese Journal of Integrative Medicine, 18, 837-845.
99. Lee H, Kim YO, Kim H, Kim SY, Noh HS, Kang SS, Cho GJ, Choi WS, Suk K. (2003) Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB Journal, 17, 1943-1944.
100. Piao HZ, Choi IY, Park JS, Kim HS, Cheong JH, Son KH, Jeon SJ, Ko KH, Kim WK. (2008) Wogonin inhibits microglial cell migration via suppression of nuclear factor-kappa B activity. International Immunopharmacology, 8, 1658-1662.
101. Son D, Lee P, Lee J, Kim H, Kim SY. (2004) Neuroprotective effect of wogonin in hippocampal slice culture exposed to oxygen and glucose deprivation. European Journal of Pharmacology, 493, 99-102. (Pubitemid 38746937)
102. Hsieh CL, Cheng CY, Tsai TH, Lin IH, Liu CH, Chiang SY, Lin JG, Lao CJ, Tang NY. (2006) Paeonol reduced cerebral infarction involving the superoxide anion and microglia activation in ischemia-reperfusion injured rats. Journal of Ethnopharmacology, 106, 208-215. (Pubitemid 43766198)
103. Wu JB, Song NN, Wei XB, Guan HS, Zhang XM. (2008) Protective effects of paeonol on cultured rat hippocampal neurons against oxygen-glucose deprivation-induced injury. Journal of Neurological Sciences, 264, 50-55.
104. Su SY, Cheng CY, Tsai TH, Hsieh CL. (2012) Paeonol protects memory after ischemic stroke via inhibiting β-secretase and apoptosis. Evidence-Based Complementary and Alternative Medicine, 2012, 932823.
105. Wang Z, Liu T, Gan L, Wang T, Yuan X, Zhang B, Chen H, Zheng Q. (2010) Shikonin protects mouse brain against cerebral ischemia/reperfusion injury through its antioxidant activity. European Journal of Pharmacology, 643, 211-217.
106. Nam KN, Son MS, Park JH, Lee EH. (2008) Shikonins attenuate microglial inflammatory responses by inhibition of ERK, Akt, and NF-kappaB: neuroprotective implications. Neuropharmacology, 55, 819-825.
107. Hu XM, Zhou MM, Hu XM, Zeng FD. (2005) Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion. Acta Pharmacologica Sinica, 26, 1454-1459.
108. Guo H, Hu LM, Wang SX, Wang YL, Shi F, Li H, Liu Y, Kang LY, Gao XM. (2011) Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity. Chinese Journal of Physiology, 54, 399-405.
109. Zhang HF, Hu XM, Wang LX, Xu SQ, Zeng FD. (2009) Protective effects of scutellarin against cerebral ischemia in rats: evidence for inhibition of the apoptosis-inducing factor pathway. Planta Medica, 75, 121-126.